Singhal Priya
SEC CIK 1769608 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | Head of Development | 8,043 | — | $2.02M | 51 | 2023-01-25 | 2026-02-09 |
Most active insiders at BIIB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Singhal Priya | Head of Development | — | $665.7K |
| 2 | Minor Lloyd | Dir | — | $239.7K |
| 3 | Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| 4 | Godbout Sean | CAO | — | — |
| 5 | Pangalos Menelas N | Dir | — | — |
| 6 | Grogan Jane | Head of Research | — | — |
| 7 | LANGER SUSAN | Dir | — | — |
| 8 | Keeney Adam | Head of Corp. Development | — | — |
| 9 | Izzar Rachid | Head of Gbl Product Strat | — | — |
| 10 | Patolawala Monish D | Dir | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +6,900 | 12.1K | +132% | $0 |
| D | 2026-02-10 | 2026-02-09 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $199.83 | -2,660 | 8,043 | -25% | -$531.5K |
| DM | 2026-02-10 | 2026-02-06 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $201.18 | -2,468 | 7,432 | -25% | -$496.5K |
| D | 2026-02-03 | 2026-01-30 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $179.89 | -582 | 7,019 | -8% | -$104.7K |
| D | 2026-02-03 | 2026-02-02 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $179.30 | -748 | 6,271 | -11% | -$134.1K |
| D | 2026-02-03 | 2026-01-30 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,829 | 7,601 | +32% | $0 |
| D | 2025-09-02 | 2025-08-29 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $132.22 | -807 | 6,289 | -11% | -$106.7K |
| D | 2025-09-02 | 2025-08-29 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,669 | 7,096 | +31% | $0 |
| D | 2025-09-02 | 2025-09-02 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $133.55 | -517 | 5,772 | -8% | -$69.0K |
| 2025-05-20 | 2025-05-19 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale | $126.25 | -3,806 | 5,427 | -41% | -$480.5K | |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,212 | 9,423 | +15% | $0 |
| D | 2025-02-12 | 2025-02-10 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $142.54 | -357 | 9,066 | -4% | -$50.9K |
| D | 2025-02-10 | 2025-02-07 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +2,216 | 8,892 | +33% | $0 |
| D | 2025-02-10 | 2025-02-07 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $141.35 | -681 | 8,211 | -8% | -$96.3K |
| D | 2025-02-03 | 2025-01-31 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $143.93 | -578 | 6,676 | -8% | -$83.2K |
| D | 2025-02-03 | 2025-01-31 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,828 | 7,254 | +34% | $0 |
| D | 2024-12-09 | 2024-12-09 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $157.21 | -110 | 5,426 | -2% | -$17.3K |
| D | 2024-12-09 | 2024-12-06 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $157.78 | -206 | 5,536 | -4% | -$32.5K |
| D | 2024-12-09 | 2024-12-06 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +426 | 5,742 | +8% | $0 |
| D | 2024-09-05 | 2024-08-30 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $204.76 | -807 | 5,747 | -12% | -$165.2K |
| D | 2024-09-05 | 2024-08-30 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,668 | 6,554 | +34% | $0 |
| D | 2024-09-05 | 2024-09-03 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $204.22 | -431 | 5,316 | -7% | -$88.0K |
| 2024-04-03 | 2024-04-02 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale | $213.09 | -93 | 4,886 | -2% | -$19.8K | |
| 2024-02-26 | 2024-02-22 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale | $221.23 | -262 | 4,886 | -5% | -$58.0K | |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,208 | 5,429 | +29% | $0 |
| DM | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $219.08 | -468 | 5,256 | -8% | -$102.5K |
| D | 2024-02-21 | 2024-02-16 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $221.49 | -108 | 5,148 | -2% | -$23.9K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,212 | 5,309 | +30% | $0 |
| D | 2024-02-13 | 2024-02-12 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $239.45 | -419 | 4,516 | -8% | -$100.3K |
| D | 2024-02-13 | 2024-02-09 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $240.98 | -374 | 4,935 | -7% | -$90.1K |
| D | 2024-02-05 | 2024-02-01 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,828 | 5,292 | +53% | $0 |
| D | 2024-02-05 | 2024-02-02 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $245.93 | -634 | 4,097 | -13% | -$155.9K |
| D | 2024-02-05 | 2024-02-01 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $247.83 | -561 | 4,731 | -11% | -$139.0K |
| D | 2023-12-12 | 2023-12-08 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +426 | 3,780 | +13% | $0 |
| D | 2023-12-12 | 2023-12-08 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $239.29 | -206 | 3,574 | -5% | -$49.3K |
| D | 2023-12-12 | 2023-12-11 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $248.00 | -110 | 3,464 | -3% | -$27.3K |
| D | 2023-09-06 | 2023-09-05 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $269.43 | -431 | 3,354 | -11% | -$116.1K |
| D | 2023-09-06 | 2023-09-01 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $267.17 | -807 | 3,785 | -18% | -$215.6K |
| D | 2023-09-06 | 2023-09-01 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,668 | 4,592 | +57% | $0 |
| D | 2023-07-05 | 2023-06-30 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $284.85 | -153 | 3,005 | -5% | -$43.6K |
| D | 2023-07-05 | 2023-07-03 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale+OE | $282.87 | -81 | 2,924 | -3% | -$22.9K |
| D | 2023-07-05 | 2023-06-30 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +315 | 3,158 | +11% | $0 |
| 2023-04-06 | 2023-04-04 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale | $277.11 | -91 | 2,843 | -3% | -$25.2K | |
| 2023-03-30 | 2023-03-28 | BIIB | Biogen | Singhal Priya | Head of Development | S - Sale | $270.06 | -568 | 2,842 | -17% | -$153.4K | |
| DM | 2023-03-06 | 2023-03-02 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $268.75 | -687 | 3,410 | -17% | -$184.6K |
| D | 2023-03-06 | 2023-03-02 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +297 | 3,554 | +9% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $278.38 | -151 | 3,800 | -4% | -$42.0K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +460 | 3,951 | +13% | $0 |
| D | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,211 | 3,863 | +46% | $0 |
| D | 2023-02-14 | 2023-02-10 | BIIB | Biogen | Singhal Priya | Head of Development | F - Tax | $286.30 | -372 | 3,491 | -10% | -$106.5K |
| 2023-01-27 | 2023-01-25 | BIIB | Biogen | Singhal Priya | Head of Development | A - Grant | $0.00 | +1,123 | 2,652 | +73% | $0 |
Purchase Sale Sale after option exercise All abbreviations